company background image
QTXB logo

QuantRx Biomedical OTCPK:QTXB Stock Report

Last Price

US$0.004

Market Cap

US$314.8k

7D

0%

1Y

-46.7%

Updated

27 Mar, 2024

Data

Company Financials

QuantRx Biomedical Corporation

OTCPK:QTXB Stock Report

Market Cap: US$314.8k

QTXB Stock Overview

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States.

QTXB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

QuantRx Biomedical Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for QuantRx Biomedical
Historical stock prices
Current Share PriceUS$0.004
52 Week HighUS$0.01
52 Week LowUS$0.000001
Beta-2.16
1 Month Change0%
3 Month Changen/a
1 Year Change-46.67%
3 Year Change-75.00%
5 Year Change-16.67%
Change since IPO-99.85%

Recent News & Updates

Recent updates

Shareholder Returns

QTXBUS Medical EquipmentUS Market
7D0%2.2%0.4%
1Y-46.7%13.3%28.8%

Return vs Industry: QTXB underperformed the US Medical Equipment industry which returned 12% over the past year.

Return vs Market: QTXB underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is QTXB's price volatile compared to industry and market?
QTXB volatility
QTXB Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: QTXB's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine QTXB's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1986n/aShalom Hirschmanhttps://www.quantrx.com/index.htm

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company’s PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs.

QuantRx Biomedical Corporation Fundamentals Summary

How do QuantRx Biomedical's earnings and revenue compare to its market cap?
QTXB fundamental statistics
Market capUS$314.79k
Earnings (TTM)-US$260.51k
Revenue (TTM)n/a

0.0x

P/S Ratio

-1.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QTXB income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$260.51k
Earnings-US$260.51k

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.0033
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-53.5%

How did QTXB perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.